Asset Sale to Healgen (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
	Feb. 28, 2023	Feb. 15, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Purchase price retention fund to cover potential indemnification claims	$ 300,000
Shares of common stock issued		27,863,899
Shares of common stock outstanding		47,098,476
Common stock par value		$ 0.01	$ 0.01		$ 0.01
Shares of common stock sales description		the Asset Sale to Healgen required the affirmative vote of the holders of a majority of the outstanding shares of the Company’s common stock (par value $0.01). 26,381,832, or 54.84% of the total outstanding shares of the Company, voted in favor of the Asset Sale to Healgen. 1,476,077, or 3.06% of the total outstanding shares, voted against the Asset Sale to Healgen. 5,990, or 0.01% of the total shares outstanding, withheld voting on the Asset Sale to Healgen.
Total consideration for sale of assets	3,000,000		$ (2,114,000)	$ 0
Net proceed	247,000
Net proceed from loans	965,000
Property related taxes	193,000
Current property related taxes	12,000
Cherokee LSA [Member]
Principal amount for interest	1,031,000
Cherokee Term Loan [Member]
Principal amount for interest	$ 252,000